Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
1
x
$
0.00
View Cart
Checkout
Home
Valproate-Autism Labyrinth
“Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)” has been added to your cart.
View cart
Valproate-Autism Labyrinth
$
30.00
Valproate-Autism Labyrinth quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 54 No. 4 Articles – 2024
Tags:
Ahmed Naguy
,
autism
,
folic acid
,
irritability
,
Maryam Alqabandi
,
risk
,
translational model
,
valproate
Description
Description
Clinical Perspective
Valproate-Autism Labyrinth
By Ahmed Naguy, Maryam Alqabandi
Related products
The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder
$
30.00
Add to cart
Details
Drug Induced Mania in a Boy with High Functioning Autism
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Pharmacology of Valproate
$
30.00
Add to cart
Details
Page load link
Go to Top